vs
Hyperscale Data, Inc.（GPUS）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
REGENXBIO Inc.的季度营收约是Hyperscale Data, Inc.的1.1倍（$30.3M vs $26.9M），Hyperscale Data, Inc.净利率更高（-112.0% vs -221.3%，领先109.4%），REGENXBIO Inc.同比增速更快（43.0% vs 38.4%），REGENXBIO Inc.自由现金流更多（$-52.8M vs $-56.2M），过去两年REGENXBIO Inc.的营收复合增速更高（39.4% vs -16.3%）
Hyperscale Data, Inc.主要提供GPU加速计算基础设施及云解决方案，服务于AI开发、大数据处理、高性能计算领域，客户覆盖北美及亚太地区的AI初创企业、大型科技公司与云服务提供商，为复杂数据处理需求交付可扩展的高效计算资源。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
GPUS vs RGNX — 直观对比
营收规模更大
RGNX
是对方的1.1倍
$26.9M
营收增速更快
RGNX
高出4.6%
38.4%
净利率更高
GPUS
高出109.4%
-221.3%
自由现金流更多
RGNX
多$3.4M
$-56.2M
两年增速更快
RGNX
近两年复合增速
-16.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $26.9M | $30.3M |
| 净利润 | $-30.1M | $-67.1M |
| 毛利率 | 14.5% | — |
| 营业利润率 | -117.8% | -190.0% |
| 净利率 | -112.0% | -221.3% |
| 营收同比 | 38.4% | 43.0% |
| 净利润同比 | -6670.3% | -31.2% |
| 每股收益（稀释后） | — | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPUSRGNX
| Q4 25 | $26.9M | $30.3M | ||
| Q3 25 | $24.3M | $29.7M | ||
| Q2 25 | $25.9M | $21.4M | ||
| Q1 25 | $25.0M | $89.0M | ||
| Q4 24 | $19.4M | $21.2M | ||
| Q3 24 | $31.1M | $24.2M | ||
| Q2 24 | $17.8M | $22.3M | ||
| Q1 24 | $38.4M | $15.6M |
净利润GPUSRGNX
| Q4 25 | $-30.1M | $-67.1M | ||
| Q3 25 | $-13.0M | $-61.9M | ||
| Q2 25 | $-19.1M | $-70.9M | ||
| Q1 25 | $-4.2M | $6.1M | ||
| Q4 24 | $-445.0K | $-51.2M | ||
| Q3 24 | $-25.5M | $-59.6M | ||
| Q2 24 | $-33.9M | $-53.0M | ||
| Q1 24 | $3.7M | $-63.3M |
毛利率GPUSRGNX
| Q4 25 | 14.5% | — | ||
| Q3 25 | 25.8% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 6.5% | 70.2% | ||
| Q3 24 | 27.5% | 48.8% | ||
| Q2 24 | -21.3% | 52.5% | ||
| Q1 24 | 47.4% | 72.6% |
营业利润率GPUSRGNX
| Q4 25 | -117.8% | -190.0% | ||
| Q3 25 | -57.8% | -176.3% | ||
| Q2 25 | -39.2% | -296.3% | ||
| Q1 25 | -25.5% | 13.6% | ||
| Q4 24 | -46.8% | -242.1% | ||
| Q3 24 | -79.2% | -256.6% | ||
| Q2 24 | -151.4% | -251.3% | ||
| Q1 24 | 9.5% | -408.8% |
净利率GPUSRGNX
| Q4 25 | -112.0% | -221.3% | ||
| Q3 25 | -53.5% | -208.3% | ||
| Q2 25 | -73.7% | -331.8% | ||
| Q1 25 | -16.8% | 6.8% | ||
| Q4 24 | -2.3% | -241.3% | ||
| Q3 24 | -82.3% | -246.3% | ||
| Q2 24 | -190.7% | -237.7% | ||
| Q1 24 | 9.7% | -405.4% |
每股收益（稀释后）GPUSRGNX
| Q4 25 | — | $-1.30 | ||
| Q3 25 | $-0.39 | $-1.20 | ||
| Q2 25 | $-2.66 | $-1.38 | ||
| Q1 25 | — | $0.12 | ||
| Q4 24 | $-8.78 | $-0.99 | ||
| Q3 24 | $-24.82 | $-1.17 | ||
| Q2 24 | $-37.81 | $-1.05 | ||
| Q1 24 | $3.32 | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.1M | $230.1M |
| 总债务越低越好 | $83.1M | — |
| 股东权益账面价值 | $119.8M | $102.7M |
| 总资产 | $313.7M | $453.0M |
| 负债/权益比越低杠杆越低 | 0.69× | — |
8季度趋势，按日历期对齐
现金及短期投资GPUSRGNX
| Q4 25 | $13.1M | $230.1M | ||
| Q3 25 | $24.8M | $274.2M | ||
| Q2 25 | $5.9M | $323.3M | ||
| Q1 25 | $4.2M | $267.9M | ||
| Q4 24 | $4.5M | $234.7M | ||
| Q3 24 | $7.9M | $255.5M | ||
| Q2 24 | $9.6M | $290.4M | ||
| Q1 24 | $18.9M | $338.7M |
总债务GPUSRGNX
| Q4 25 | $83.1M | — | ||
| Q3 25 | $80.0M | — | ||
| Q2 25 | $88.5M | — | ||
| Q1 25 | $92.8M | — | ||
| Q4 24 | $96.7M | — | ||
| Q3 24 | $104.8M | — | ||
| Q2 24 | $106.8M | — | ||
| Q1 24 | $30.0M | — |
股东权益GPUSRGNX
| Q4 25 | $119.8M | $102.7M | ||
| Q3 25 | $55.9M | $161.5M | ||
| Q2 25 | $5.5M | $213.7M | ||
| Q1 25 | $6.3M | $274.2M | ||
| Q4 24 | $8.6M | $259.7M | ||
| Q3 24 | $2.7M | $301.4M | ||
| Q2 24 | $26.7M | $348.3M | ||
| Q1 24 | $59.0M | $390.7M |
总资产GPUSRGNX
| Q4 25 | $313.7M | $453.0M | ||
| Q3 25 | $242.4M | $525.2M | ||
| Q2 25 | $213.5M | $581.0M | ||
| Q1 25 | $218.5M | $490.9M | ||
| Q4 24 | $220.8M | $466.0M | ||
| Q3 24 | $231.5M | $519.1M | ||
| Q2 24 | $270.8M | $569.4M | ||
| Q1 24 | $299.8M | $629.2M |
负债/权益比GPUSRGNX
| Q4 25 | 0.69× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 16.06× | — | ||
| Q1 25 | 14.71× | — | ||
| Q4 24 | 11.19× | — | ||
| Q3 24 | 38.41× | — | ||
| Q2 24 | 4.00× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.7M | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | $-56.2M | $-52.8M |
| 自由现金流率自由现金流/营收 | -208.7% | -174.0% |
| 资本支出强度资本支出/营收 | 68.6% | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-87.1M | $-126.4M |
8季度趋势，按日历期对齐
经营现金流GPUSRGNX
| Q4 25 | $-37.7M | $-52.3M | ||
| Q3 25 | $-17.8M | $-56.0M | ||
| Q2 25 | $-3.1M | $-49.3M | ||
| Q1 25 | $-4.0M | $33.6M | ||
| Q4 24 | $-9.2M | $-31.6M | ||
| Q3 24 | $3.7M | $-40.5M | ||
| Q2 24 | $-3.7M | $-45.5M | ||
| Q1 24 | $-10.2M | $-55.5M |
自由现金流GPUSRGNX
| Q4 25 | $-56.2M | $-52.8M | ||
| Q3 25 | $-20.6M | $-56.5M | ||
| Q2 25 | $-3.5M | $-49.7M | ||
| Q1 25 | $-6.8M | $32.6M | ||
| Q4 24 | $-9.3M | $-32.7M | ||
| Q3 24 | $2.6M | $-40.9M | ||
| Q2 24 | $-5.9M | $-46.0M | ||
| Q1 24 | $-11.6M | $-56.0M |
自由现金流率GPUSRGNX
| Q4 25 | -208.7% | -174.0% | ||
| Q3 25 | -84.5% | -189.9% | ||
| Q2 25 | -13.5% | -232.8% | ||
| Q1 25 | -27.3% | 36.6% | ||
| Q4 24 | -47.6% | -154.2% | ||
| Q3 24 | 8.4% | -168.9% | ||
| Q2 24 | -33.4% | -206.2% | ||
| Q1 24 | -30.3% | -358.5% |
资本支出强度GPUSRGNX
| Q4 25 | 68.6% | 1.7% | ||
| Q3 25 | 11.5% | 1.7% | ||
| Q2 25 | 1.5% | 1.8% | ||
| Q1 25 | 11.5% | 1.2% | ||
| Q4 24 | 0.3% | 5.1% | ||
| Q3 24 | 3.6% | 1.3% | ||
| Q2 24 | 12.6% | 2.1% | ||
| Q1 24 | 3.7% | 3.6% |
现金转化率GPUSRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPUS
| Transferred Over Time | $10.4M | 39% |
| Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities | $5.8M | 21% |
| Hotel And Real Estate Operations | $4.8M | 18% |
| Other | $4.0M | 15% |
| Turn On Green | $2.0M | 7% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
